
    <!doctype html>

    <html lang="en">
    <head>
        <meta charset="utf-8">    
        <script type="text/JavaScript" src="https://MomentJS.com/downloads/moment.js"></script>
        <script type="text/JavaScript" src="https://momentjs.com/downloads/moment-timezone-with-data.min.js"></script>
        <title>The importance of BCL-XL in the onset of cognitive deficits associated to 22q11 deletion syndrome</title>
        <style>
            
    * {
        font-family: "Trebuchet MS", Helvetica, sans-serif;
    }
    
        </style>
        <script type="text/JavaScript">
            
	function LT(t) {
        var m = moment.utc(t).tz(moment.tz.guess());
		document.write(m.format('MMMM Do YYYY, HH:mm z'));
	};
    function time_between(start, end) {
        var s = moment.utc(start);
        var e = moment.utc(end);
        var now = moment();
        return (s<=now) && (now<=e);
    };
    function update_visibility() {
        var now = moment();
        var elems = document.getElementsByClassName("visible_at_time");
        for(var i=0; i<elems.length; i++) {
            s = moment.utc(elems[i].dataset.start);
            e = moment.utc(elems[i].dataset.end);
            if ( (s<=now) && (now<=e) ) {
                elems[i].style.display = "block";
            } else {
                elems[i].style.display = "none";
            }
        }
    };
    setInterval(update_visibility, 60*1000);
    
        </script>
        <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
    </head>
    <body>
        <h3>
            <a href="https://neuromatch.io">Neuromatch</a> 3 /
            <script type="text/JavaScript">LT("2020-10-27 12:30");</script>
            /
            Track 3
            /
            Interactive talk
            <div class="visible_at_time" data-start="2020-10-27 12:30" data-end="2020-10-27 12:45">
                <a href='https://www.youtube.com/watch?v=R0Jbw983eYg'><i class="fa fa-youtube-play" style="font-size:24px;color:red"></i></a>
                <a href='https://www.youtube.com/watch?v=R0Jbw983eYg'>Watch now on YouTube</a>
            </div>
        </h3>
        <h1>The importance of BCL-XL in the onset of cognitive deficits associated to 22q11 deletion syndrome</h1><h2>Eva Cristina de Oliveira Figueiredo</h2><h3>Tamara Zehnder Dep. of Fundamental Neurosciences, UNIL, Lausanne, Switzerland; Anthony Laugeray, Dep. of Fundamental Neurosciences, UNIL, Lausanne, Switzerland;  Denise Gastaldo, Dep. of Fundamental Neurosciences, UNIL, Lausanne, Switzerland; Tommy L. Lewis, Dep. of Neuroscience, Mortimer B. Zuckerman MBB inst.; Kavil Inst. For Brain Science, USA; Daniela Rossi, Maugeri Foundation, UNIPV, Pavia, Italy; Fulvio Magara, CPN, CHUV, Lausanne, Switzerland; Joseph Gogos, Dep. of Physiology and Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, USA; Claudia Bagni, Dep. of Fundamental Neurosciences, UNIL, Lausanne, Switzerland; Manuel Mameli, Dep. of Fundamental Neurosciences, UNIL, Lausanne, Switzerland; Franck Polleux, Dep. of Neuroscience, Mortimer B. Zuckerman MBB inst.; Kavil Inst. For Brain Science, USA; Paola Bezzi, Dep. of Fundamental Neurosciences, UNIL, Lausanne, Switzerland and Dep of Physiology and Pharmacology, Univ. La Sapienza, Rome, Italy</h3><h2>Abstract</h1><p>22q11 deletion syndrome (DS) is a syndrome characterized by structural abnormalities in dendrites maturation and spines formation and by behavioral and cognitive deficits (Karayiorgou et al., 2010).  Among the genes deleted in the 22q11, six encode for mitochondrial proteins. Here, we examined mitochondrial genes expression in brain tissues of LgDel mice, a mouse model of 22q11DS (Meechan et al., 2009), and found that, among other mitochondrial-related genes, Bcl-Xl was specifically downregulated in cortical tissues and not in hippocampal tissues. We thus checked whether the decreased levels of Bcl-Xl could have a role in the neuroanatomical abnormalities associated to 22q11DS. At first, we analysed the mitochondrial distribution and the morphology of neurons in vivo by labelling single cells with a plasmid expressing a cytoplasmic fluorescent protein (mTAGBFP2) and a mitochondrial matrix-targeted fluorescent protein (mt-YFP) with IUE. Morphometric analysis of these parameters revealed remarkable differences between the LgDel and control mice. Then, we chronically treated LgDel mice with a biologically active peptide consisting of a domain of BCL-XL fused to the protein transduction domain of the HIV-TAT protein and found a significant rescue of mitochondrial phenotypes and a consistent improvement of the dendritic and spine abnormalities. Finally, the beneficial effect of TAT peptide was confirmed on cognitive deficits of LgDel mice.<br/>Support contributed: SNFS NCCR “Synapsy” (51NF40-158776) and SNFS (26074366) to PB.<br/></p>
        <script type="text/JavaScript">
            update_visibility();
        </script>
    </body>
    </html>
    